Immunohistochemistry showed that CD39 was downregulated in lung parenchyma, epithelial bronchial cells, and the endothelial cells of pulmonary muscular arteries in the COPD group. This evidence concerns the gene ENTPD1 and chronic obstructive pulmonary disease.